Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Retatrutide for Sale > Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories
Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories buy - large image1
Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories buy - image1
Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories buy - image2
Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories buy - image3
Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories buy - image4
Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories buy - image5
Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories buy - image6

Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories

COA 6843 Inquiries

Unit Price:

$100/G FOB

Get Latest Price
CAS No.:

2381089-83-2

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Tide

Packaging:

10vials/box

Price valid (until):

2027-09-02

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Retatrutide is a first-in-class triple agonist peptide that simultaneously activates the Glucose-dependent Insulinotropic Polypeptide receptor (GIPR), Glucagon-Like Peptide-1 receptor (GLP-1R), and Glucagon receptor (GCGR). Engineered as a 39-amino-acid peptide based on native GIP with Aib substitutions at positions 2 and 20, a C20 fatty diacid modification at Lys17 via a gamma-Glu-(AEEA) linker, and C-terminal amidization, Retatrutide achieves an extended plasma half-life of approximately 6 days through albumin binding

    As a research reagent, Retatrutide is intended for in vitro and in vivo metabolic research, including studies of obesity, type 2 diabetes, non-alcoholic steatohepatitis (NASH), and cardiometabolic syndrome. The triple receptor activation profile provides synergistic effects on appetite suppression, insulin sensitization, energy expenditure, and lipid mobilization that exceed what single or dual receptor agonists can achieve.


      Mechanism of Action


    Retatrutide binds to all three human receptors with high potency:

    • GIPR EC₅₀: 0.064 nM — Enhances glucose-dependent insulin secretion, improves pancreatic beta-cell function, modulates adipose tissue lipid metabolism

    • GLP-1R EC₅₀: 0.775 nM — Promotes glucose-dependent insulin release, suppresses glucagon secretion, delays gastric emptying, reduces appetite through CNS pathways

    • GCGR EC₅₀: 5.79 nM — Increases energy expenditure and hepatic glucose output, enhances lipolysis, promotes fatty acid oxidation

    Mechanism summary:

    • Appetite Suppression: GLP-1 and GIP activation in the hypothalamus reduces hunger and increases satiety

    • Delayed Gastric Emptying: Slows food leaving the stomach, prolonging post-meal fullness

    • Increased Energy Expenditure: Glucagon activation raises resting metabolic rate and promotes thermogenesis

    • Enhanced Lipolysis: Glucagon signaling stimulates fat breakdown and fatty acid oxidation

    • Insulin Sensitization: GIP activation improves insulin sensitivity in peripheral tissues


      Clinical Research Data  


    Retatrutide has demonstrated remarkable metabolic improvements across Phase II and Phase III clinical trials (TRIUMPH program):

    Weight Loss:

    • Phase III TRIUMPH-1: 12mg dose — average 28.3% weight loss (70.3 lbs) over 80 weeks

    • 104-week extension: average 30.3% weight loss (85 lbs), approaching bariatric surgery efficacy

    • 65.3% of participants achieved BMI below 30 (no longer obese)

    Glycemic Control:

    • HbA1c reduced by up to 2.2% in T2D patients

    • 82% of T2D participants reached HbA1c ≤ 6.5%

    Liver Health:

    • Over 80% reduction in liver fat content (NAFLD/NASH)

    Comorbidity Relief:

    • Knee osteoarthritis pain reduced by up to 73% (WOMAC score)

    • Obstructive sleep apnea improved by 60.6% (AHI reduction)

    Cardiometabolic:

    • Reduced blood pressure, triglycerides, LDL cholesterol, waist circumference, and inflammatory markers

    * Data from published Phase II and Phase III clinical trials. Product is investigational. For research reference only.


      Research Applications


    • Obesity & Energy Metabolism Research: In vivo studies of weight regulation, appetite control, and energy expenditure in rodent and primate models

    • Type 2 Diabetes Studies: Investigation of glucose homeostasis, insulin secretion, and beta-cell preservation

    • NASH / NAFLD Research: Evaluation of hepatic steatosis reduction, liver inflammation, and fibrosis markers

    • Cardiometabolic Research: Studies of lipid profiles, blood pressure, and cardiovascular risk markers

    • Receptor Pharmacology: In vitro characterization of triple receptor signaling, cAMP assays, and receptor binding studies

    • Peptide Drug Development: Reference compound for next-generation multi-target agonist design and formulation studies

    ✓ Triple agonist targeting GIPR, GLP-1R, and GCGR receptors
    ✓ ≥99% purity verified by HPLC, independently tested by FREEDOM or JANOSHIK
    ✓ Lyophilized powder in sterile glass vials, 10 vials per box
    ✓ Available in 5mg, 10mg, 20mg, 30mg, 40mg per vial
    ✓ Customizable cap colors available for bulk orders

    Items Specifications
    Product Name Retatrutide (GIP/GLP-1/Glucagon Triple Agonist)
    CAS No. 2381089-83-2
    Molecular Formula C₂₂₁H₃₄₂N₄₆O₆₈
    Molecular Weight 4731.33 g/mol
    Purity ≥99% (HPLC)
    Form  Lyophilized Powder 
    Package 10 vials / box
    Available Sizes

    5mg / 10mg / 20mg / 30mg / 40mg / 60mg

    Storage

    Cool, dry place; after reconstitution refrigerate at 2-8°C

    Usage For research use only
    Contact Salas:Lev WhatsApp:+852 5172 9003  Gmail:lechumrinhus867@gmail.com


      Product Images 


     Product Images

    Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 1 Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 2 Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 3 Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 4


      Shipping Information  


    Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 5

    Global Air Shipping · Door-to-Door Delivery

    All research reagents are shipped via air freight with professional packaging. Orders dispatch within 3 days, with door-to-door delivery directly to your lab or office.

    Shipping Method: Air Freight

    Delivery: Door-to-Door

    Dispatch Time: Within 3 days of order

    Packaging: Professional secure packaging


      Packaging & Customization  


    Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 6

    Customizable Cap Colors

    13mm aluminum-plastic caps (6.2mm inner height) with four finish options — matte, glossy, OFF, and tear-off — in 30+ colors. Meet your brand differentiation and product line identification needs.


    • Cap Size: 13mm Aluminum-Plastic

    • Finishes: Matte / Glossy / OFF / Tear-off

    • Colors: 30+ Available

    • Packaging: 10 vials / tray / box

    * MOQ for custom colors — please consult our sales team.


    Safety & Handling


    Precautions

    • This product is for research use only 

    • Allow vials to equilibrate to room temperature before opening to prevent condensation from affecting product stability

    • Reconstitute with appropriate buffer or sterile water according to experimental protocols. Prepare fresh solutions when possible

    • Dispose of unused product and packaging in accordance with local regulations for chemical/biological waste.



      FAQ


    Q1. How do you ensure product quality?

    A1. Each product is independently tested by FREEDOM or JANOSHIK third-party laboratory according to product type, including HPLC purity analysis (≥99%), LC-MS/MS mass spectrometry verification.

    Q2. Why buy from us instead of other suppliers?

    A2. We are a direct manufacturer offering competitive prices and guaranteed quality. We support customizable cap colors, provide fast air shipping with door-to-door delivery, and deliver honest, timely, and efficient service with extensive experience in domestic and foreign trade. Our products are independently verified by world-class third-party testing laboratories (FREEDOM or JANOSHIK).

    Q3. How to place an order?

    A3. Contact our sales Lev via WhatsApp (+852 5172 9003) or email (lechumrinhus867@gmail.com) with your requirements including product, size, and quantity. We will send a complete quotation including freight. After confirming the order and receiving payment/deposit, we arrange delivery within 3 days upon receiving the bank receipt.

    Q4. Do you have stock?

    A4. We keep stock for most standard products and sizes. For some rare products or custom specifications, additional synthesis time is required. Contact our sales team for current stock availability.

    Q5. What is your MOQ?

    A5.  the minimum order is 1 box (10 vials). Available sizes: 5mg, 10mg, 20mg, 30mg, and 40mg per vial. Larger quantities and custom sizes are available — contact sales for bulk pricing.


    Q6. Is there a discount for bulk orders?

    A6. Yes, different quantities qualify for different discount tiers. Larger orders always receive better pricing. Contact our sales team for a tailored quotation based on your specific needs.

    Q7. Can you provide custom synthesis or modified peptides?

    A7. Yes, we offer custom peptide synthesis including sequence modifications, different fatty acid chain lengths, alternative linker chemistries, and various packaging options. Contact our technical team with your specifications for a custom quote.


      Laboratory & Production  


    Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 7 Advanced Analytical Testing  Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 8Sterile Production Process  

    Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 9Finished Product Quality              Shop Retatrutide (CAS 2381089-83-2)|99% Purity|Research Grade Peptides|Purity tested by renowned testing laboratories-Detailed Image 10Modern R&D Laboratory

    ECHEMI Editorial Reference
    Retatrutide is a novel triple agonist peptide of the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide inhibits human GCGR, GIPR and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively and mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191 and 0.794 nM, respectively. It is an important tool for obesity research.Retatrutide potently activates the GLP-1R signaling pathway to stimulate glucose-dependent insulin secretion through activity at the GIP receptor (GIPR) or the GLP-1R.Retatrutide is a synthetic peptide with glucose-lowering effects. It is an antidiabetic agent against type 2 diabetes (T2D), stimulating insulin and suppressing glucagon secretion in a glucose-dependent manner.Retatrutide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake and reduce body weight in patients with type 2 diabetes.

    Certificates

    Basic Info
    Product Name:

    Retatrutide

    Other Name:

    Retatrutide;GIPR/GLP-1R;LY3437943Retatrutide;Retalutide;Retatrutide (sodium salt);Retatrutide RT5;retatrutide 5mg;Retatratide

    CAS No.:

    2381089-83-2

    Molecular Formula:

    C221H342N46O68

    InChIKeys:

    MLOLQJNKXBNWFW-SAGGEDDASA-N

    Molecular Weight:

    4731.33

    EC Number:

    200-001-8

    Color/Form:

    White lyophilized

    Categories:

    Polypeptide

    Characteristics
    Water Solubility:

    Soluble in water (5mg/ml).

    Storage Conditions:

    -20°C

    Critical Temperature & Pressure:

    -20°C

    Research
    Class:

    Triple agonist — GCGR, GIPR, GLP-1R

    Status:

    Investigational (Phase 3)

    Mechanism:

    Simultaneously activates glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Engineered from the native GIP backbone with amino acid substitutions to confer GCGR and GLP-1R activity.

    EC50 (Human GCGR):

    5.79 nM

    EC50 (Mouse GIPR):

    0.191 nM

    EC50 (Mouse GLP1R):

    0.794 nM

    EC50 (Mouse GCGR):

    2.32 nM

    EC50 (Human GLP1R):

    0.775 nM

    EC50 (Human GIPR):

    0.0643 nM

    Source:

    Jastreboff AM, et al. N Engl J Med. 2023;389(6):514-526.DOI

    Clinical Development:

    NCT04881760; NCT05882045; NCT06354660

    References
    ChEMBL:

    CHEMBL5095485

    DrugBank:

    DB18993

    KEGG DRUG:

    D12430

    PubChem:

    PubChem

    Disclaimer:

    Retatrutide is an investigational compound not yet approved by FDA or EMA. This listing is for industrial and laboratory research use only. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptide

    Location:

    3rd Floor, Room 323, Building 3, No. 87 West Jiancai Road, Changping District, Beijing

    Year of Establishment:

    2024

  • Inquiry History
    6843 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Retatrutide 2381089-83-2

    3 MT Mar 28, 2026
    United Kingdom

    Retatrutide - 2381089-83-2

    1 G Feb 10, 2026
    United States

    Retatrutide CAS 2381089-83-2 10mg vial

    20 MT Mar 7, 2026
    United States

    Factory Retatrutide API 99% Purity CAS 2381089-83-2

    5 KG Nov 10, 2025
    United Kingdom

    Peptide powder Retatrutide 99% pure for Body building cas 2381089-83-2 Weight Loss Peptide with COA

    1 MT Mar 22, 2026
    United States

    2381089-83-2

    100 G Jul 14, 2026
    United States

    2381089-83-2

    100 G Feb 24, 2026
    United States

    2381089-83-2

    100 MT Dec 9, 2023
    United States

    Retatrutide 2381089-83-2

    200 MG May 16, 2026
    United Kingdom

    2381089-83-2 retatrutide

    300 MG Feb 13, 2026
    United States

    Retatrutide 2381089-83-2 wholesale

    500 MT Nov 3, 2023
    United States

    Retatrutide CAS 2381089-83-2 99%

    10 PCS Feb 21, 2026
    Poland

    CAS 2381089-83-2 (Custom Peptide)

    40 MT Apr 10, 2026
    Austria

    Peptide Retatruide CAS 2381089-83-2

    100 MT Apr 4, 2026
    Austria

    Retatrutide CAS 2381089-83-2 10mg vial

    20 PCS Feb 10, 2026
    United States

    Tirzepatide 99.9% Liquid 2381089-83-2 TeruiOP

    1 MT Sep 6, 2023
    United States

    GLP-1 / GIP Retatrutide cas 2381089-83-2

    1 MT Oct 16, 2024
    United States

    Retatrutide 99% High Quality CAS 2381089-83-2

    1 G Jan 23, 2026
    United States

    Injection Peptide Tirzepatide/Retatrutide/ Semaglutide Peptides CAS 2381089-83-2

    10  Oct 21, 2023
    Australia

    GMP Grade 99% Retatrutide Lyophilized Powder CAS 2381089-83-2

    10 G Jun 12, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.